Please login to the form below

Not currently logged in
Email:
Password:

Weber Shandwick creates digital European role

Stephen Davies joins from Ruder Funn
Weber-Shandwick_Stephen-Davies

Communications agency Weber Shandwick has created a new European digital health director role to help capitalise on the growing digital health market.

Stephen Davies has been announced as the first to hold the role, reporting to UK health managing director, Lucie Harper and European health managing director, Rachael Pay.

Davies joins from Ruder Finn, where he led the digital team. He will oversee Weber Shandwick's European digital offering for new and existing health clients.

“Digital has always been important to our health clients but our own research has shown that it's reluctance rather than regulation that prevents some brands from engaging in two-way digital activity,” said Harper.

“The landscape is changing however and digital health demand is growing rapidly. With Stephen on-board we can meet this demand and further develop this part of our business,” she added.

“Weber Shandwick is a leader in health communications and a pioneer in recognising the creative disruption taking place in the space. I'm delighted to be joining a company with the vision and foresight to capitalise on the opportunities this brings,” said Davies.

11th February 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics